(Q37577521)

21 August 2017

Topical ranibizumab as a treatment of corneal neovascularization (English)

1 reference

corneal neovascularization

21 August 2017

1 reference

1 reference

7

Reza Dana

1 reference

21 August 2017

Giulio Ferrari

1

1 reference

21 August 2017

Mohammad H Dastjerdi

2

1 reference

21 August 2017

Andre Okanobo

3

1 reference

21 August 2017

Sheng-Fu Cheng

4

1 reference

21 August 2017

Francisco Amparo

5

1 reference

21 August 2017

Nambi Nallasamy

6

1 reference

21 August 2017

1 July 2013

1 reference

21 August 2017

6

1 reference

inferred from page(s)

published in

Cornea

1 reference

21 August 2017

32

1 reference

21 August 2017

7

1 reference

21 August 2017

992-997

1 reference

Clinical safety of ranibizumab in age-related macular degeneration

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Anti-VEGF therapy: comparison of current and future agents

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Vascular endothelial growth factor mediates corneal nerve repair

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphyrin ether

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Corneal neovascularization

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Fine needle diathermy occlusion of corneal vessels

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Corneal penetration of topical and subconjunctival bevacizumab

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Comparison of the effects of bevacizumab and ranibizumab injection on corneal angiogenesis in an alkali burn induced model.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

The impact of subconjuctivally injected EGF and VEGF inhibitors on experimental corneal neovascularization in rat model

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

The effect of subconjunctival ranibizumab on primary pterygium: a pilot study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Role of lasers in eye care

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Refractory squamous cell carcinoma of the conjunctiva treated with subconjunctival ranibizumab (Lucentis): a two-year study.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Recurrent herpes simplex keratitis after verteporfin photodynamic therapy for corneal neovascularization

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Subconjunctival ranibizumab for squamous cell carcinoma of the conjunctiva with corneal extension

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Bevacizumab application delays epithelial healing in rabbit cornea.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Photodynamic therapy for corneal neovascularisation and lipid degeneration

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Inhibition of Hemangiogenesis and LymphangiogenesisafterNormal-Risk Corneal Transplantation by Neutralizing VEGF Promotes Graft Survival

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3920979

Treatment of inflamed pterygia or residual pterygial bed

3 December 2018

1 reference

12 December 2020

Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group

1 reference

12 December 2020

The effect of topical bevacizumab on corneal neovascularization

1 reference

12 December 2020

Subconjunctival bevacizumab for corneal neovascularization

1 reference

12 December 2020

VEGF inhibitors for the treatment of neovascular age-related macular degeneration

1 reference

12 December 2020

Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas

1 reference

12 December 2020

[Origin of corticosteroid glaucoma]

1 reference

12 December 2020

Photodynamic Therapy for Corneal Neovascularization

1 reference

12 December 2020

Loss and restoration of immune privilege in eyes with corneal neovascularization

1 reference

12 December 2020

10.1097/ICO.0B013E3182775F8D

Identifiers

DOI

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

23407316

1 reference